6Oooke T,geeves J,Lannigan A, et al.The value of the human ep idermal growth factor receptor-2(HER2)as a prognostic marker[J].Eur Cancer, 2001,37(1): 3-10.
7Kaptain S,Tan LK,Ohen B. HER-2/neu and breast cancer[J]. Oiagnmol Pathol,2001,10(3):139--152.
8Evan$ A J,Pinder S E,Ellis I O,et al. Correlations between the mammographic features of ductat carcinoma in situ(DCIS)and c-erbB-2 oneogene expression.Nottingham Breast Team[J].Olin Eadiol,1994,49(8):559 562.
4Tan PH, Ho JT, Ng EH, et al. Pathologic-radiologic correlations in screen-detected dutal carcinoma of the breast: findings of the Singapore breast screening project. Int J Cancer, 2000, 90(3): 231
5Goscin CP, Bermen CG, Clark RA. Magnetic resonance imaging of the breast. Cancer Control, 2001, 8(5): 399
6Silva JM, Dominguez G, Gonzalez R,et al. Presence of tumor DNA in plasma of breast cancer patients: clinico-pathological correlation. Cancer Res, 1999, 59(9): 3252
7Feig SA. Ductal carcinoma in-situ: imlacations for screening mammography. Radio Clin North AM, 2003, 38(6): 653
8Kopans DB. Atlas of breast imaging. Philadelphia: Williams and Wilkins, 1998, 98
9American College of Radiology (ACR). Breast imaging reporting and date System(BI-RADS). 3rd edition. Reston, [VA]: American College of Radioology, 1998, 1
7Muttarak M, Kongmebhol P, Sukhamwan$ N. Breast calcifications: which are malignant[ J]. Singapore Med J,2009,50(9):907-914.
8Estevez LG, Alvarez L, Segui MA, et al, Current persl~tives of treat- ment of ductal carcinoma in situ [ J ]. Cancer Treatment Rev, 2010,36(7) :507-510.
9Ellen Shaw De Paredes,Atlas of mammography[ M]. 2007:249.
10Baker R, Rogers KD, Shepherdand N. New relationships between breast microcalcifieations and cancer[ J ]. British Journal of Cancer, 2010,103(7) :1034-1039.
